One-Year Uptake of Pneumococcal Conjugate Vaccine: A National Survey of Family Physicians and Pediatricians

References

1. ↵
   American Academy of Family Physicians. AFP clinical recommendations: pneumococcal conjugate immunization. Available at: URL: http://www.aafp.org/x1556.xml.
2. ↵
   Anonymous. American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000; 106: 362–6.

   OpenUrlAbstract/FREE Full Text
3. ↵
   Advisory Committee on Immunization Practices. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000; 49(RR-9): 1–35.

   OpenUrlPubMed
4. ↵
   Rennels MB, Edwards KM, Keyserling HL, et al. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Pediatrics 1998; 101: 604–11.

   OpenUrlAbstract/FREE Full Text
5. ↵
   Black S, Shinefield HR, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000; 19: 187–95.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001; 344: 403–9.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   Centers for Disease Control. Vaccine price list. Available at: URL: http://www.cdc.gov/nip/vfc/cdc_vac_price_list.htm.
8. ↵
   Davis MM, Andreae M, Freed GL. Physicians’ early challenges related to the pneumococcal conjugate vaccine. Ambul Pediatr 2001; 1: 302–5.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   Anonymous. Recommended childhood immunization schedule—United States, 2001. MMWR Morb Mortal Wkly Rep 2001; 50: 7–10, 19.

   OpenUrlPubMed
10. ↵
    Lieu TA, Davis RL, Capra AM, et al. Variation in clinician recommendations for multiple injections during adoption of inactivated polio vaccine. Pediatrics 2001; 107: e49.

    OpenUrlAbstract/FREE Full Text
11. ↵
    Woodin KA, Rodewald LE, Humiston SG, Carges MS, Schaffer SJ, Szilagyi PG. Physician and parent opinions: are children becoming pincushions for immunizations? Arch Pediatr Adolesc Med 1995; 149: 845–9.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    Kolasa MS, Petersen TJ, Brink EW, Bulim ID, Stevenson JM, Rodewald LE. Impact of multiple injections on immunization rates among vulnerable children. Am J Prev Med 2001; 21: 261–6.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    Freed GL, Bordley WC, Clark SJ, Konrad TR. Reactions of pediatricians to a new Centers for Disease Control recommendation for universal immunization of infants with hepatitis B vaccine. Pediatrics 1993; 91: 699–702.

    OpenUrlAbstract/FREE Full Text
14. ↵
    Freed GL, Bordley WC, Clark SJ, Konrad TR. Universal hepatitis B immunization of infants: reactions of pediatricians and family physicians over time. Pediatrics 1994; 93: 747–51.

    OpenUrlAbstract/FREE Full Text
15. ↵
    Freed GL, Freeman VA, Clark SJ, Konrad TR, Pathman DE. Pediatrician and family physician agreement with and adoption of universal hepatitis B immunization. J Fam Pract 1996; 42: 587–92.

    OpenUrlPubMedWeb of Science
16. ↵
    Pathman DE, Konrad TR, Freed GL, Freeman VA, Koch GG. The awareness-to-adherence model of the steps to clinical guideline compliance. Med Care 1996; 34: 873–89.

    OpenUrlCrossRefPubMedWeb of Science
17. Freed GL, Clark SJ, Konrad TR, Pathman DE. Factors affecting physicians’ early adoption of combined DTP-Hib vaccine. Ambulatory Child Health 1997; 3: 27–33.
18. ↵
    Ipp M, Macarthur C, Winders P, Gold R. Influenza vaccination of high-risk children: a survey of three physician groups. Can J Public Health 1998; 89: 415–8.

    OpenUrlPubMedWeb of Science
19. Takayama JI, Iser JP, Gandelman A. Regional differences in infant immunization against hepatitis B: did intervention work? Prev Med 1999; 28: 160–6.

    OpenUrlCrossRefPubMedWeb of Science
20. Schaffer SJ, Bruno S. Varicella immunization practices and the factors that influence them. Arch Pediatr Adolesc Med 1999; 153: 357–62.

    OpenUrlCrossRefPubMedWeb of Science
21. ↵
    Kimmel S, Puczynski S, McCoy RC, Puczynski MS. Practices of family physicians and pediatricians in administering poliovirus vaccine. J Fam Pract 1999; 48: 594–600.

    OpenUrlPubMedWeb of Science
22. ↵
    Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282: 1458–65.

    OpenUrlCrossRefPubMedWeb of Science
23. ↵
    Cochi SL, Fleming DW, Hull HF, Preblud SR, Orenstein WA. Haemophilus influenzae b polysaccharide vaccine. Physician acceptance and use of a new vaccine. Am J Dis Child 1986; 140: 1226–30.

    OpenUrlCrossRefPubMed
24. ↵
    Newman RD, Taylor JA. Reactions of pediatricians to the recommendation for universal varicella vaccination. Arch Pediatr Adolesc Med 1998; 152: 792–6.

    OpenUrlCrossRefPubMedWeb of Science
25. ↵
    Shefer A, Briss P, Rodewald L, et al. Improving immunization coverage rates: an evidence-based review of the literature. Epidemiol Rev 1999; 21: 96–142.

    OpenUrlFREE Full Text
26. ↵
    Briss PA, Rodewald LR, Hinman AR, et al. Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med 2000; 18(1 Suppl): 97–140.

    OpenUrlPubMedWeb of Science
27. ↵
    Anonymous. National, state, and urban area vaccination coverage levels among children aged 19–35 months—United States, 2000. MMWR Morb Mortal Wkly Rep 2001; 50: 637–41.

    OpenUrlPubMed
28. ↵
    Zhou F, Bisgard KM, Yusuf HR, Deuson RR, Bath SK, Murphy TV. Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis. Pediatrics 2002; 110: 653–61.

    OpenUrlAbstract/FREE Full Text
29. ↵
    U.S. Census Bureau. Health insurance detailed table: 2000. Current Population Survey. Available at: http://www.census.gov/hhes/hlthins/hlthin00/dtable10.html.
30. ↵
    Asch DA, Jedrziewski K, Christakis NA. Response rates to mailed surveys published in medical journals. J Clin Epidemiol 1997; 50: 1129–36.

    OpenUrlCrossRefPubMedWeb of Science
31. ↵
    Cummings SM, Savitz LA, Konrad TR. Reported response rates to mailed physician questionnaires. Health Serv Res 2001; 35: 1347–55.

    OpenUrlPubMedWeb of Science
32. ↵
    Anonymous. From the Centers for Disease Control and Prevention. Updated recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortage-Advisory Committee on Immunization Practices. JAMA 2002; 287: 833–4.

    OpenUrlCrossRefPubMedWeb of Science
33. ↵
    LeBaron CW, Massoudi M, Stevenson J, Lyons B. Vaccination coverage and physician distribution in the United States, 1997. Pediatrics 2001; 107: e31.

    OpenUrlAbstract/FREE Full Text
34. ↵
    Davis MM, Zimmerman JL, Wheeler JR, Freed GL. Childhood vaccine purchase costs in the public sector: past trends, future expectations. Am J Public Health 2002; 92: 1982–7.

    OpenUrlPubMedWeb of Science